Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Oncopeptides AB
AB
Active
Org 5565966438
Luntmakargatan 46, 111 37
Stockholm
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2000 · 25 years old
20-49 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Oncopeptides AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (4)
EH
Eric Henrik Bergentoft
External Signatory
External Signatory
2022
LG
Lars Gustaf Kylberg
Chief Auditor
Chief Auditor
2024
ES
Eva Sabina Marianne Nordström
Chief Executive Officer
Chief Executive Officer
2020
SE
Sofia Elin Elisabeth Heigis
Chief Executive Officer
Chief Executive Officer
2022
Former (9)
KS
Karolina Susanna Vilval
External Signatory
External Signatory
2020 – 2022
SA
Stig Anders Jacob Lindberg
Chief Executive Officer
Chief Executive Officer
2020 – 2023
AJ
Anders Jussi Martin-Löf
Chief Executive Officer
Chief Executive Officer
2020 – 2022
MJ
Marty John Duvall
Chief Executive Officer
Chief Executive Officer
2020 – 2022
HL
Holger Lembrér
External Signatory
External Signatory
2023 – 2023
MS
Monica Shaw
Chief Executive Officer
Chief Executive Officer
2023 – 2023
BS
Björn Sture Bernhard Peters Ohlsson
Chief Auditor
Chief Auditor
2020 – 2020
AB
Annika Beata Bladh Muskantor
External Signatory
External Signatory
2022 – 2023
AK
Anna Kristina Svanberg
Chief Auditor
Chief Auditor
2020 – 2024
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (4)
PA
Per Anders Göte Samuelsson
Board of Directors
Board of Directors
2020
BM
Brian Michael Stuglik
Board of Directors
Board of Directors
2020
PW
Per Wold-Olsen
Chairman
Chairman
2020
CE
Christine Elizabeth Rankin
Board of Directors
Board of Directors
2025
Former (4)
JA
Jennifer Ann Jackson
Board of Directors
Board of Directors
2020 – 2025
CM
Cecilia Margaretha Daun Wennborg
Board of Directors
Board of Directors
2020 – 2025
JU
Jarl Ulf Birger Jungnelius
Board of Directors
Board of Directors
2020 – 2025
JK
Jonas Karl Olof Brambeck
Board of Directors
Board of Directors
2020 – 2021
Aktionærer
Pr. seneste årsrapport
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Oncopeptides AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network